Related Experiment Videos
Spondylarthropathy and selective IgA deficiency
S H Sprenkels1, A Linssen, T E Feltkamp
1The Netherlands Ophthalmic Research Institute, Amsterdam.
Rheumatology International
|January 1, 1995
Summary
This study found no serum IgA in a patient with spondylarthropathy (SpA). This suggests immunoglobulin A may not play a role in the development of SpA.
Area of Science:
- Immunology
- Rheumatology
- Clinical Medicine
Background:
- Spondyloarthritis (SpA) is a group of inflammatory diseases affecting the spine and joints.
- The role of immunoglobulin A (IgA) in the pathogenesis of SpA remains incompletely understood.
- Reactive arthritis, a form of SpA, can be triggered by infections, including urethritis.
Observation:
- A young male patient presented with active spondylarthropathy, including sacroiliitis, enthesopathy, and inflammatory low back pain.
- The patient's symptoms developed subsequent to a sexually transmitted urethritis.
- Notably, no serum immunoglobulin A (IgA) was detected in this patient throughout the observation period.
Findings:
- Despite active disease, the patient exhibited a complete absence of detectable serum IgA.
- The spondylarthropathy resolved after several months and showed no progression over a three-year follow-up.
- This case presents a unique instance of SpA without detectable serum IgA.
Implications:
- The absence of serum IgA in this SpA patient challenges the presumed role of IgA in the disease's pathogenesis.
- This finding may prompt a re-evaluation of humoral immunity's contribution to SpA development.
- Further research is warranted to explore the immunological mechanisms underlying SpA in IgA-deficient individuals.